VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21 | 0.0% | 3,142 | 0.0% | 0.00% | – |
| Q2 2023 | $21 | 0.0% | 3,142 | 0.0% | 0.00% | – |
| Q1 2023 | $21 | -61.1% | 3,142 | -42.7% | 0.00% | – |
| Q4 2022 | $54 | -99.9% | 5,483 | 0.0% | 0.00% | – |
| Q3 2022 | $54,000 | -10.0% | 5,483 | 0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -51.2% | 5,483 | -49.6% | 0.00% | – |
| Q1 2022 | $123,000 | -62.7% | 10,872 | -48.4% | 0.00% | -100.0% |
| Q4 2021 | $330,000 | -8.6% | 21,060 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $361,000 | -60.2% | 21,060 | -50.0% | 0.00% | -50.0% |
| Q2 2021 | $906,000 | +43.4% | 42,120 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $632,000 | -43.4% | 42,120 | +172.6% | 0.00% | – |
| Q4 2020 | $1,117,000 | +644.7% | 15,452 | 0.0% | 0.00% | – |
| Q3 2020 | $150,000 | -14.8% | 15,452 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $176,000 | – | 15,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |